Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
36%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
26%
ALSO IN THNR
THNR
18
HOLDINGS
41%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 18.2% | 13.8% | 13.8% | |
| ABBVIE INC | 8.2% | 4.7% | 4.7% | |
| ASTRAZENECA PLC | 5.2% | 4.6% | 4.6% | |
| MERCK & CO. INC. | 3.9% | 4.9% | 3.9% | |
| AMGEN INC | 3.9% | 6.0% | 3.9% | |
MEDX Overweight Relative to THNR
| NOVARTIS AG-ADR | 7.1% | |
| JOHNSON & JOHNSON | 5.3% | |
| ALKERMES PLC | 4.8% | |
| BRISTOL-MYERS SQUIBB CO | 4.7% | |
| IONIS PHARMACEUTICALS, INC. | 4.7% | |
| ELI LILLY & CO | 4.4% | |
| ALNYLAM PHARMACEUTICALS INC | 3.7% | |
| ABBVIE INC | 3.5% | |
| BIOGEN IDEC INC | 3.0% | |
| CRISPR THERAPEUTICS AG | 2.9% |
MEDX Underweight Relative to THNR
| NOVO-NORDISK A/S-SPONS ADR | -14.6% | |
| ARROWHEAD PHARMACEUTICALS, INC. | -6.0% | |
| CHUGAI PHARMACEUTICAL CO LTD | -5.4% | |
| INNOVENT BIOLOGICS, INC. | -5.0% | |
| SHIONOGI & CO LTD | -4.1% | |
| CHINA PHARMACEUTICAL GROUP | -4.1% | |
| REGENERON PHARMACEUTICALS | -3.2% | |
| SCHOLAR ROCK HOLDING CORP. | -2.3% | |
| VIKING THERAPEUTICS, INC. | -2.2% | |
| AMGEN INC | -2.1% |